Topics

A jury didn't buy Kapoor’s defense that he did not know what his lieutenants were doing. That’s good news for anyone hoping we can discourage other pharma entrepreneurs from lining their pockets while harming patients. https://buff.ly/2DNAusx 

17:49 EDT 2 May 2019 | STAT

A jury didn't buy Kapoor’s defense that he did not know what his lieutenants were doing. That’s good news for anyone hoping we can discourage other pharma entrepreneurs from lining their pockets while harming patients. https://buff.ly/2DNAusx 

Original Article: A jury didn't buy Kapoor’s defense that he did not know what his lieutenants were doing. That’s good news for anyone hoping we can discourage other pharma entrepreneurs from lining their pockets while harming patients. https://buff.ly/2DNAusx 

NEXT ARTICLE

More From BioPortfolio on "A jury didn't buy Kapoor’s defense that he did not know what his lieutenants were doing. That’s good news for anyone hoping we can discourage other pharma entrepreneurs from lining their pockets while harming patients. https://buff.ly/2DNAusx "

Quick Search